Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2024 1

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
The impact of risk factors on aspirin's efficacy for the prevention of preterm birth.
Nuss EE, Hoffman MK, Goudar SS, Kavi A, Metgud M, Somannavar M, Okitawutshu J, Lokangaka A, Tshefu A, Bauserman M, Tembo AM, Chomba E, Carlo WA, Figueroa L, Krebs NF, Jessani S, Saleem S, Goldenberg RL, Kurhe K, Das P, Hibberd PL, Achieng E, Nyongesa P, Esamai F, Liechty EA, Bucher S, Goco N, Hemingway-Foday J, Moore J, McClure EM, Silver RM, Derman RJ; Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas Study Group. Nuss EE, et al. Am J Obstet Gynecol MFM. 2023 Oct;5(10):101095. doi: 10.1016/j.ajogmf.2023.101095. Epub 2023 Aug 12. Am J Obstet Gynecol MFM. 2023. PMID: 37574046 Free PMC article. Clinical Trial.
CONCLUSION: Low-dose aspirin's ability to prevent preterm birth, hypertensive disorders of pregnancy, and perinatal mortality was similar in nulliparous women with and without additional risk factors. Professional societies should consider recommending low-dose a …
CONCLUSION: Low-dose aspirin's ability to prevent preterm birth, hypertensive disorders of pregnancy, and perinatal mortality …
Corrigendum to The impact of risk factors on aspirin's efficacy for the prevention of preterm birth. American Journal of Obstetrics & Gynecology MFM. Volume 5, Issue 10, October 2023, 101095.
Nuss EE, Hoffman MK, Goudar SS, Kavi A, Metgud M, Somannavar M, Okitawutshu J, Lokangaka A, Tshefu A, Bauserman M, Tembo AM, Chomba E, Carlo WA, Figueroa L, Krebs NF, Jessani S, Saleem S, Goldenberg RL, Kurhe K, Das P, Hibberd PL, Achieng E, Nyongesa P, Esamai F, Liechty EA, Bucher S, Goco N, Hemingway-Foday J, Moore J, McClure EM, Silver RM, Derman RJ, Patel A; Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas Study Group. Nuss EE, et al. Am J Obstet Gynecol MFM. 2024 Apr;6(4):101309. doi: 10.1016/j.ajogmf.2024.101309. Epub 2024 Feb 23. Am J Obstet Gynecol MFM. 2024. PMID: 38395633 Free PMC article. No abstract available.